Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05975424 · ClinicalTrials.gov registry record
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1
A clinical trial of Spinal Cord Injuries, sponsored by Lineage Cell Therapeutics.
- Active
- Registry status
- 25
- Enrollment target
- 6
- Study locations
NCT05975424 is a study of Spinal Cord Injuries that is active but no longer recruiting, run by Lineage Cell Therapeutics. The registered enrollment target is 25 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (59% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT05975424, a study of Spinal Cord Injuries, is active but no longer recruiting, sponsored by Lineage Cell Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a LTFU study for cervical SCI subjects that were administered AST-OPC1 cells in the main study AST-OPC1-01.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI)
Study Locations (6)
California
- University of Southern California - Los Angeles
- Stanford University - Palo Alto
Georgia
- Shepherd Center - Atlanta
Illinois
- RUSH University Medical Center - Chicago
Pennsylvania
- Thomas Jefferson University - Philadelphia
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2033-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05975424
The ClinicalTrials.gov registry entry for NCT05975424 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (59% lower). The listed sponsor is Lineage Cell Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT05975424 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT05975424 about?
NCT05975424 is a clinical study titled "LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1". This is a LTFU study for cervical SCI subjects that were administered AST-OPC1 cells in the main study AST-OPC1-01.
What is the current status of trial NCT05975424?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2018-06-13. Estimated completion is 2033-01-14.
What conditions does trial NCT05975424 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT05975424?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05975424?
This trial is sponsored by Lineage Cell Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05975424 being conducted?
This trial has 6 study locations across California, Georgia, Illinois, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Effectiveness of the Collaborative Community Clinic for Persons With Spinal Cord Injury and Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.